|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2009-10-28
|
|
pubmed:abstractText |
Inflammatory breast cancer (IBC) is the most aggressive form of breast cancer. Circulating tumor cells (CTCs) are an independent prognostic factor in metastatic breast cancer. The aim of this study was to assess the prognostic value of baseline CTCs in metastatic IBC patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1569-8041
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1824-8
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19556320-Adult,
pubmed-meshheading:19556320-Aged,
pubmed-meshheading:19556320-Aged, 80 and over,
pubmed-meshheading:19556320-Breast Neoplasms,
pubmed-meshheading:19556320-Female,
pubmed-meshheading:19556320-Humans,
pubmed-meshheading:19556320-Kaplan-Meier Estimate,
pubmed-meshheading:19556320-Middle Aged,
pubmed-meshheading:19556320-Neoplastic Cells, Circulating,
pubmed-meshheading:19556320-Prognosis
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Circulating tumor cells in metastatic inflammatory breast cancer.
|
|
pubmed:affiliation |
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
